In addition, lung adenocarcinoma patients with high expression of both AIB1 and CXCR4 displayed the poorest survival, whereas patients with low expression of AIB1 and CXCR4 had the best survival (P < 0.001, Fig. 6d). This evidence concerns the gene NCOA3 and lung adenocarcinoma.